Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery

• Status: Not yet recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators' goal is to compare the efficacy of three different management strategies (sacral neuromodulation, botulinum toxin, M receptor antagonist) in treating consistent OAB in patients with SVMs after surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Xuanwu Hospital, Beijing
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; onabotulinumtoxinA; Tolterodine Tartrate

Criteria

Inclusion Criteria:

• •Patient diagnosed with spinal vascular diseases including Intradural arteriovenous malformation,Intradural arteriovenous fistula,Dural arteriovenous fistula,Extradural arteriovenous malformation,Paravertebral arteriovenous malformation,Paravertebral arteriovenous fistula,cobbs' syndrome,and other spinal arteriovenous metameric syndromes involve the spinal cord.

• patient not received surgical or interventional treatment before

• patient with normal cardiac, renal and hepatic function

• patient capable of understanding the content of the patient information / Informed Consent Form

• patient willing and able to participate in the registry

• patients have consistent OAB after surgery

Exclusion Criteria:

• •patient received surgical treatment or interventional treatment before

• patient is pregnant

• patient allergic to iodine

• patient unable to complete follow-up

• patient with cerebral lesions

• patient with other spinal lesions

• patient with cardiac, renal or hepatic dysfunction